ClinicalTrials.Veeva

Menu

Hearing Aid Education and Adaptation System

H

Healthcare Technologies and Methods

Status

Completed

Conditions

Hearing Loss

Treatments

Other: TELLYHealth

Study type

Interventional

Funder types

Industry
NIH

Identifiers

NCT02839759
HTM092016
R44AG045947 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This RCT will have two arms: A control group that receives the standard of care from audiologists and an experimental group that receives both the standard of care and the at-home use of the TELLYHealth intervention. Subjects in each group will complete questionnaires at enrollment, mid-study and at the end of the study.

Full description

HTM will develop the "TELLYHealth (tm) system" that will provide education on hearing aid use and maintenance. HTM will conduct a randomized controlled trial (RCT) to quantify the benefits of TELLYHealth to patients and audiologists including: reductions in hearing handicap, improved knowledge of hearing aid handling, use and communications strategies; and improved audiologist aftercare. The investigators will recruit 80 subjects (half in each group) and each subject will participate in the study for 8-12 weeks.

Enrollment

52 patients

Sex

All

Ages

50+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Speaks and reads English fluently
  • Has mild (25-40 dB) to severe (70-95 dB) monaural sensorineural hearing loss
  • Will be fitted with one or two hearing aids at the time of enrollment
  • Owns a standard TV
  • Has Internet access at home
  • Has sufficient corrected vision to watch videos and read text on the TV and mobile device
  • No signs of dementia

Exclusion criteria

  • Lives with person who has enrolled in the study

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

52 participants in 2 patient groups

TELLYHealth Group
Experimental group
Description:
Subjects will receive the standard of care in hearing aid education and the TELLYHealth intervention for use over an 8 to12-week period and will be followed by their audiologist for 8 to 12 weeks.
Treatment:
Other: TELLYHealth
Standard of Care Group
No Intervention group
Description:
Subjects will receive the standard of care in hearing aid education and will be followed by their audiologist for 8 to 12 weeks.

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems